The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

TIL Cell Therapy – free webinar for patients and caregivers

Forums Cutaneous Melanoma Community TIL Cell Therapy – free webinar for patients and caregivers

  • Post
    Debbie Churgai
      Join the MRF on Tuesday, March 19 at 7:00pm ET for an informative discussion featuring Dr. Allison Betof Warner, Director of the Melanoma Program at the Stanford Cancer Institute and melanoma survivor and patient advocate Jamie Tomasko. This webinar will give you a deep dive look into TIL Cell Therapy, the newest groundbreaking treatment for advanced melanoma. During the webinar, patients and caregivers will learn about the efficacy, durability, process and timeframe of this new FDA-approved treatment. Time for Q&A will be available so come ready to ask questions! Register today at
    Viewing 0 reply threads
    • Replies
    Viewing 0 reply threads
    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics